NCT04206709

Brief Summary

The purpose of this study is to examine the immediate effect of aerobic exercise effort on clinical and experimental pain, knee active range of motion and function in people after total knee replacement.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2019

Completed
6 months until next milestone

First Posted

Study publicly available on registry

December 20, 2019

Completed
12 days until next milestone

Study Start

First participant enrolled

January 1, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2020

Completed
Last Updated

December 20, 2019

Status Verified

July 1, 2019

Enrollment Period

4 months

First QC Date

July 4, 2019

Last Update Submit

December 19, 2019

Conditions

Keywords

exercise induced analgesia

Outcome Measures

Primary Outcomes (3)

  • Pressure Pain Threshold (PPT)

    PPT examination by designated device

    Change from Baseline PPT will be assessed right after the intervention

  • Visual Analogue Scale (VAS)

    100mm VAS -A vertical VAS ruler with a slider indicator and a scale of 0-100 mm on the ruler's front side was used. the lower edge marked "0" and the upper edge marked "100". The back side of the ruler included a "happy" face figure at the lower edge representing "no pain" and a "sad" face at the upper edge representing "severe pain". Higher VAS scores equal more pain.

    Change from Baseline VAS will be assessed right after the intervention

  • 10 Meter Walk Test

    timed 10 meter walk test

    Change from 10 meter walk test baseline outcome will be assessed right after the intervention

Secondary Outcomes (2)

  • Knee Active Range of Motion (aROM)

    Change in aROM baseline will be assessed right after the intervention

  • Timed Up and Go (TUG)

    Change from TUG test outcome will be assessed right after the intervention

Study Arms (2)

aerobic effort

EXPERIMENTAL

Active upper limbs pedaling

Procedure: aerobic effort

passive pedaling

SHAM COMPARATOR

passive pedaling

Other: passive pedaling

Interventions

Active upper limbs pedaling while maintaining a pulse calculated to be approximately 60% of the predicted maximum heart rate of each patient for 20 minutes.

aerobic effort

20 minutes passive pedaling by upper limbs.

passive pedaling

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Candidates for unilateral total knee replacement surgery in the Department of Orthopedics 'A", at f the Galilee Medical Center.
  • years and older.
  • Diagnosed with osteoarthritis.
  • Consent to participate in the trial.
  • Understand simple instructions.
  • Capable of walking with walking aid independently or supervised.
  • Allowed to perform medium-intensity aerobic exercise to-60% of their predicted maximum pulse.

You may not qualify if:

  • \* Individuals who have a physical limitation preventing them from performing active pedaling in upper limbs for 20 minutes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Galilee Medical Center

Nahariya, Israel

RECRUITING

Study Officials

  • Einat Kodesh, PhD

    University of Haifa

    PRINCIPAL INVESTIGATOR
  • Noa Katz-Betzalel

    Galilee Medical Center

    STUDY DIRECTOR

Central Study Contacts

Noa Katz-Betzalel

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2019

First Posted

December 20, 2019

Study Start

January 1, 2020

Primary Completion

May 1, 2020

Study Completion

May 1, 2020

Last Updated

December 20, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations